Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Aug 1;133(3):705-12.
doi: 10.1002/ijc.28052. Epub 2013 Feb 25.

Overdiagnosis among women attending a population-based mammography screening program

Affiliations
Free PMC article

Overdiagnosis among women attending a population-based mammography screening program

Ragnhild Sørum Falk et al. Int J Cancer. .
Free PMC article

Abstract

Increased incidence of ductal carcinoma in situ (DCIS) and invasive breast cancer (IBC) after introduction of organized screening has prompted debate about overdiagnosis. The aim was to examine the excess in incidence of DCIS and IBC during the screening period and the deficit after women left the program, and thereby to estimate the proportion of overdiagnosis. Women invited to the Norwegian Breast Cancer Screening Program were analyzed for DCIS or IBC during the period 1995-2009. Incidence rate ratios (IRRs) were calculated for attended vs. never attended women. The IRRs were adjusted by Mantel-Haenszel (MH) method and applied to a set of reference rates and a reference population to estimate the proportion of overdiagnosis during the women's lifespan after the age of 50 years. A total of 702,131 women were invited to the program. An excess of DCIS and IBC was observed among women who attended screening during the screening period; prevalently invited women aged 50-51 years had a MH IRR of 1.86 (95% CI 1.65-2.09) and subsequently invited women aged 52-69 years had a MH IRR of 1.56 (95% CI 1.45-1.68). In women aged 70-79 years, a deficit of 30% (MH IRR 0.70, 95% CI 0.62-0.80) was observed 1-10 years after they left the screening program. The estimated proportion of overdiagnosis varied from 10 to 20% depending on outcome and whether the women were invited or actually screened. The results highlight the need for individual data with longitudinal screening history and long-term follow-up as a basis for estimating overdiagnosis.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Attendance (%) by age for prevalently and subsequently invited women to the Norwegian Breast Cancer Screening Program.
Figure 2
Figure 2
Incidence of DCIS and IBC (a) and IBC (b) per 100,000 women-years by age at diagnosis. Solid line: reference (period approach). Dotted line: reference multiplied with the MH IRRs. Abbreviations: DCIS: ductal carcinoma in situ; IBC: invasive breast cancer; MH IRR: incidence rate ratio of attending vs. never-attending women adjusted by county and calendar period using the Mantel-Haenszel method.

Comment in

Similar articles

Cited by

References

    1. Glass AG, Lacey JV, Jr, Carreon JD, et al. Breast cancer incidence, 1980–2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status. J Natl Cancer Inst. 2007;99:1152–61. - PubMed
    1. Sorum R, Hofvind S, Skaane P, et al. Trends in incidence of ductal carcinoma in situ: the effect of a population-based screening programme. Breast. 2010;19:499–505. - PubMed
    1. Vainio H, Bianchini F, editors. IARC handbooks of cancer prevention. Breast cancer screening. Vol. 7. Lyon: IARC Press; 2002. p. 229.
    1. Virnig BA, Wang SY, Shamilyan T, et al. Ductal carcinoma in situ: risk factors and impact of screening. J Natl Cancer Inst Monogr. 2010;2010:113–6. - PMC - PubMed
    1. Kalager M, Adami HO, Bretthauer M, et al. Overdiagnosis of invasive breast cancer due to mammography screening: results from the Norwegian screening program. Ann Intern Med. 2012;156:491–9. - PubMed

Publication types

MeSH terms